Sodium Nitroprusside (Page 4 of 4)

HOW SUPPLIED

Sodium nitroprusside injection is supplied in amber-colored, single-dose 50 mg/2 mL Fliptop Vials (NDC 71839-120-01).

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

To protect Sodium nitroprusside injection from light, it should be stored in its carton until it is used.

Distributed by:
BE Pharmaceuticals Inc.
203 New Edition Court
Cary, NC 27511

Manufactured by:

belogo

Biological E. Limited
Plot No. 4, Survey no. 542/P, Biotech Park Phase-II,
Kolthur Village, Shameerpet Mandal, Medchal, Telangana 500078, India.

Revised: July 2021

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Sodium Nitroprusside Injection 50mg/2mL (25mg/mL) — Vial Label

nitroprussideviallabel
(click image for full-size original)

Sodium Nitroprusside Injection 50mg/2mL (25mg/mL) — Carton Label

nitroprussidecartonlabel
(click image for full-size original)

Sodium Nitroprusside Injection 50mg/2mL (25mg/mL) — Sleeve Box Label

nitroprussidesleevecarton
(click image for full-size original)

Sodium Nitroprusside Injection 50mg/2mL (25mg/mL) — Light Protective Sleeve Label

nitroprussidesleevelabel
(click image for full-size original)

SODIUM NITROPRUSSIDE sodium nitroprusside injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:71839-120
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Sodium Nitroprusside (Nitroprusside) Sodium Nitroprusside 50 mg in 2 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:71839-120-01 1 VIAL in 1 CARTON contains a VIAL
1 2 mL in 1 VIAL This package is contained within the CARTON (71839-120-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA214971 07/12/2021
Labeler — BE Pharmaceuticals Inc. (081499296)
Establishment
Name Address ID/FEI Operations
Biological E. Limited 871410645 ANALYSIS (71839-120), MANUFACTURE (71839-120)

Revised: 07/2021 BE Pharmaceuticals Inc.

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.